Tumor site influences efficacy of MEKi and immunotherapy combinations in a preclinical model of cholangiocarcinoma
肿瘤部位影响胆管癌临床前模型中MEK抑制剂和免疫疗法联合治疗的疗效
期刊:Hepatology
影响因子:15.8
doi:10.1097/HEP.0000000000001439
Hammons, Jacklyn N; Warren, Emilie K; Wittling, Megen C; Bennett, Frances J; Rangel-Rivera, Guillermo O; Mack, Alexis F; Phillips, Maggie J; Robinson, Brian S; Krasinskas, Alyssa M; Horvat, Natalie K; Ruffin, Ayana T; Liu, Yuan; Cao, Yichun; Azad, Nilofer N S; Yarchoan, Mark M; Heumann, Thatcher; Keler, Tibor; Maithel, Shishir K; Paulos, Chrystal M; Lesinski, Gregory B
